» Articles » PMID: 33604786

Energetic Dissection of Mab-Specific Reversible Self-Association Reveals Unique Thermodynamic Signatures

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2021 Feb 19
PMID 33604786
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Reversible self-association (RSA) remains a challenge in the development of therapeutic monoclonal antibodies (mAbs). We recently analyzed the energetics of RSA for five IgG mAbs (designated as A-E) under matched conditions and using orthogonal methods. Here we examine the thermodynamics of RSA for two of the mAbs that showed the strongest evidence of RSA (mAbs C and E) to identify underlying mechanisms.

Methods: Concentration-dependent dynamic light scattering and sedimentation velocity (SV) studies were carried out for each mAb over a range of temperatures. Because self-association was weak, the SV data were globally analyzed via direct boundary fitting to identify best-fit models, accurately determine interaction energetics, and account for the confounding effects of thermodynamic and hydrodynamic nonideality.

Results: mAb C undergoes isodesmic self-association at all temperatures examined, with the energetics indicative of an enthalpically-driven reaction offset by a significant entropic penalty. By contrast, mAb E undergoes monomer-dimer self-association, with the reaction being entropically-driven and comprised of only a small enthalpic contribution.

Conclusions: Classical interpretations implicate van der Waals interactions and H-bond formation for mAb C RSA, and electrostatic interactions for mAb E. However, noting that RSA is likely coupled to additional equilibria, we also discuss the limitations of such interpretations.

Citing Articles

A scaling relationship between thermodynamic and hydrodynamic interactions in protein solutions.

Kingsbury J, Starr C, Gokarn Y Biophys J. 2024; 123(22):3871-3883.

PMID: 39360382 PMC: 11617628. DOI: 10.1016/j.bpj.2024.09.032.


An automated interface for sedimentation velocity analysis in SEDFIT.

Schuck P, To S, Zhao H PLoS Comput Biol. 2023; 19(9):e1011454.

PMID: 37669309 PMC: 10503714. DOI: 10.1371/journal.pcbi.1011454.


An automated interface for sedimentation velocity analysis in SEDFIT.

Schuck P, To S, Zhao H bioRxiv. 2023; .

PMID: 37425873 PMC: 10327192. DOI: 10.1101/2023.05.14.540690.


Simulation of Gilbert theory for self-association in sedimentation velocity experiments: a guide to evaluate best fitting models.

Bishop G, Correia J Eur Biophys J. 2023; 52(4-5):281-292.

PMID: 36881128 DOI: 10.1007/s00249-023-01634-3.


Comparative Thermodynamics of the Reversible Self-Association of Therapeutic mAbs Reveal Opposing Roles for Linked Proton- and Ion-Binding Events.

Hopkins M, Antonopoulos I, Parupudi A, Bee J, Bain D Pharm Res. 2023; 40(6):1383-1397.

PMID: 36869246 DOI: 10.1007/s11095-023-03485-1.

References
1.
Ecker D, Jones S, Levine H . The therapeutic monoclonal antibody market. MAbs. 2014; 7(1):9-14. PMC: 4622599. DOI: 10.4161/19420862.2015.989042. View

2.
Razinkov V, Treuheit M, Becker G . Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools. J Biomol Screen. 2015; 20(4):468-83. DOI: 10.1177/1087057114565593. View

3.
Shire S, Shahrokh Z, Liu J . Challenges in the development of high protein concentration formulations. J Pharm Sci. 2004; 93(6):1390-402. DOI: 10.1002/jps.20079. View

4.
Philo J, Arakawa T . Mechanisms of protein aggregation. Curr Pharm Biotechnol. 2009; 10(4):348-51. DOI: 10.2174/138920109788488932. View

5.
Alford J, Kendrick B, Carpenter J, Randolph T . High concentration formulations of recombinant human interleukin-1 receptor antagonist: II. Aggregation kinetics. J Pharm Sci. 2007; 97(8):3005-21. DOI: 10.1002/jps.21205. View